Roizman B - Search Results

1

Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1.

Smith KD, Mezhir JJ, Bickenbach K, Veerapong J, Charron J, Posner MC, Roizman B, Weichselbaum RR. Smith KD, et al. Among authors: roizman b. J Virol. 2006 Feb;80(3):1110-20. doi: 10.1128/JVI.80.3.1110-1120.2006. J Virol. 2006. PMID: 16414988 Free PMC article.

2

Herpes simplex virus 1 activates cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late genes.

Advani SJ, Weichselbaum RR, Roizman B. Advani SJ, et al. Among authors: roizman b. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4825-30. doi: 10.1073/pnas.0730735100. Epub 2003 Mar 28. Proc Natl Acad Sci U S A. 2003. PMID: 12665617 Free PMC article.

3

Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1.

Advani SJ, Durand LO, Weichselbaum RR, Roizman B. Advani SJ, et al. Among authors: roizman b. J Virol. 2003 Nov;77(22):11927-32. doi: 10.1128/jvi.77.22.11927-11932.2003. J Virol. 2003. PMID: 14581529 Free PMC article.

4

Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses.

Mezhir JJ, Advani SJ, Smith KD, Darga TE, Poon AP, Schmidt H, Posner MC, Roizman B, Weichselbaum RR. Mezhir JJ, et al. Among authors: roizman b. Cancer Res. 2005 Oct 15;65(20):9479-84. doi: 10.1158/0008-5472.CAN-05-1927. Cancer Res. 2005. PMID: 16230412

5

ReVOLT: radiation-enhanced viral oncolytic therapy.

Advani SJ, Mezhir JJ, Roizman B, Weichselbaum RR. Advani SJ, et al. Among authors: roizman b. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):637-46. doi: 10.1016/j.ijrobp.2006.06.034. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011442 Review.

6

Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity.

Veerapong J, Bickenbach KA, Shao MY, Smith KD, Posner MC, Roizman B, Weichselbaum RR. Veerapong J, et al. Among authors: roizman b. Cancer Res. 2007 Sep 1;67(17):8301-6. doi: 10.1158/0008-5472.CAN-07-1499. Cancer Res. 2007. PMID: 17804745

7

The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.

Advani SJ, Brandimarti R, Weichselbaum RR, Roizman B. Advani SJ, et al. Among authors: roizman b. J Virol. 2000 Jan;74(1):8-15. J Virol. 2000. PMID: 10590085 Free PMC article.

8

E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.

Advani SJ, Weichselbaum RR, Roizman B. Advani SJ, et al. Among authors: roizman b. J Virol. 2000 Sep;74(17):7842-50. doi: 10.1128/jvi.74.17.7842-7850.2000. J Virol. 2000. PMID: 10933691 Free PMC article.

9

The role of cdc2 in the expression of herpes simplex virus genes.

Advani SJ, Weichselbaum RR, Roizman B. Advani SJ, et al. Among authors: roizman b. Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10996-1001. doi: 10.1073/pnas.200375297. Proc Natl Acad Sci U S A. 2000. PMID: 10995483 Free PMC article.

10

cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factor.

Advani SJ, Weichselbaum RR, Roizman B. Advani SJ, et al. Among authors: roizman b. J Virol. 2001 Nov;75(21):10326-33. doi: 10.1128/JVI.75.21.10326-10333.2001. J Virol. 2001. PMID: 11581401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

632 results

Search Page

Filters